{
  "id": "2069f1cccaa3784c",
  "title": "ADCs in Breast Cancer : Shaping the Future of HER2 and TROP - 2 Targeted Therapy",
  "description": "20251212T053000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/adcs-in-breast-cancer-shaping-the-future-of-her2-and-trop-2-targeted-therapy",
  "published_at": "20251212T053000Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/adcs-in-breast-cancer-shaping-the-future-of-her2-and-trop-2-targeted-therapy",
    "url_mobile": "",
    "title": "ADCs in Breast Cancer : Shaping the Future of HER2 and TROP - 2 Targeted Therapy",
    "seendate": "20251212T053000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/e264e62b6c53c4f808f1e663fbd909197e1253f3-2912x1632.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}